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AbstrAct
Objective To evaluate the impact of sharing electronic 
health records (EHRs) with patients and map it across 
six domains of quality of care (ie, patient- centredness, 
effectiveness, efficiency, timeliness, equity and safety).
Design Systematic review and meta- analysis.
Data sources CINAHL, Cochrane, Embase, HMIC, 
Medline/PubMed and PsycINFO, from 1997 to 2017.
Eligibility criteria Randomised trials focusing on adult 
subjects, testing an intervention consisting of sharing 
EHRs with patients, and with an outcome in one of the 
six domains of quality of care.
Data analysis The Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses guidelines were 
followed. Title and abstract screening were performed 
by two pairs of investigators and assessed using the 
Cochrane Risk of Bias Tool. For each domain, a narrative 
synthesis of the results was performed, and significant 
differences in results between low risk and high/
unclear risk of bias studies were tested (t- test, p<0.05). 
Continuous outcomes evaluated in four studies or more 
(glycated haemoglobin (HbA1c), systolic blood pressure 
(SBP) and diastolic blood pressure (DBP)) were pooled as 
weighted mean difference (WMD) using random effects 
meta- analysis. Sensitivity analyses were performed for 
low risk of bias studies, and long- term interventions only 
(lasting more than 12 months).
Results Twenty studies were included (17 387 
participants). The domain most frequently assessed was 
effectiveness (n=14), and the least were timeliness 
and equity (n=0). Inconsistent results were found for 
patient- centredness outcomes (ie, satisfaction, activation, 
self- efficacy, empowerment or health literacy), with 
54.5% of the studies (n=6) demonstrating a beneficial 
effect. Meta- analyses showed a beneficial effect in 
effectiveness by reducing absolute values of HbA1c (unit: 
%; WMD=−0.316; 95% CI −0.540 to −0.093, p=0.005, 
I2=0%), which remained significant in the sensitivity 
analyses for low risk of bias studies (WMD= −0.405; 
95% CI −0.711 to −0.099), and long- term interventions 
only (WMD=−0.272; 95% CI −0.482 to −0.062). A 
significant reduction of absolute values of SBP (unit: mm 
Hg) was found but lost in sensitivity analysis for studies 
with low risk of bias (WMD= −1.375; 95% CI −2.791 to 
0.041). No significant effect was found for DBP (unit: mm 
Hg; WMD=−0.918; 95% CI −2.078 to 0.242, p=0.121, 
I2=0%). Concerning efficiency, most studies (80%, 
n=4) found either a reduction of healthcare usage or 
no change. A beneficial effect was observed in a range 
of safety outcomes (ie, general adherence, medication 
safety), but not in medication adherence. The proportion 
of studies reporting a beneficial effect did not differ 
between low risk and high/unclear risk studies, for the 
domains evaluated.
Discussion Our analysis supports that sharing EHRs 
with patients is effective in reducing HbA1c levels, a 
major predictor of mortality in type 2 diabetes (mean 
decrease of −0.405, unit: %) and could improve patient 
safety. More studies are necessary to enhance meta- 
analytical power and assess the impact in other domains 
of care.
Protocol registration http://www. crd. york. ac. uk/ 
PROSPERO (CRD42017070092).
IntroductIon
Providing patients with access to elec-
tronic health records (EHRs) may improve 
quality of care by providing patients with 
their personal health information, and 
involving them as key stakeholders in 
the self- management of their health and 
disease.1 With the widespread use of these 
digital solutions, there is a growing need 
to evaluate their impact, in order to better 
understand their risks and benefits, and 
to inform health policies that are both 
patient- centred and evidence- based.
According to the Institute of Medicine 
(IOM), there are six domains of health-
care quality: patient- centredness, effec-
tiveness, efficiency, safety, timeliness and 
equity.2 Patient- centred care is based on 
the provision of services that respect 
and respond to individual patients’ pref-
erences and needs, and incorporates 
these aspects in clinical decisions and 
processes.2 3 Effective healthcare services 
result ultimately in measurable improve-
ments in health outcomes,4 while ensuring 
the prevention of errors and adverse 
effects, ie, ensuring patient safety.2 Other 
 on D
ecem
ber 10, 2020 by guest. P
rotected by copyright.
http://qualitysafety.bm
j.com
/
B
M
J Q
ual S
af: first published as 10.1136/bm
jqs-2019-010581 on 12 June 2020. D
ow
nloaded from
 
1020 Neves AL, et al. BMJ Qual Saf 2020;29:1019–1032. doi:10.1136/bmjqs-2019-010581
Systematic review
dimensions of quality care delivery include minimising 
waste of resources (ie, efficiency), minimising delays 
in the provision of care (ie, timeliness) and avoiding 
differences in the provision of services to all groups of 
healthcare users (ie, equity).2
Despite the claims on the theorised benefits of 
providing patients with access to EHRs, there is still 
a considerable lack of evidence of their demonstrated 
impact. Though evidence suggests that these interven-
tions improve patient satisfaction and communica-
tion5 6 no clear benefits were found on effectiveness.5 
Previous studies5 6 were also unable to find a beneficial 
effect on efficiency measures, such as number of face- 
to- face visits and telephone appointments.
Five landmark reviews provided a comprehen-
sive characterisation of the literature published until 
2013.5–9 One of them5 included studies evaluating the 
impact of both paper- based and electronic records, a 
heterogeneity that challenges the identification of indi-
vidual benefits of the digital approach. The authors of 
previous systematic reviews highlight the paucity of 
published papers, and a tendency to include small and 
methodologically less robust studies,5 with a high risk 
of bias.9 In fact, only one systematic review specifically 
including randomised trials was published in 2012, 
having found only two studies investigating the impact 
on effectiveness.7 Recent discussions around patients’ 
rights and data ownership have acted as strong drivers 
to allocate resources to interventions capitalising on 
EHRs with patient access.10 Therefore, it is plausible 
that the more recent literature has provided new 
evidence to shed light on this subject.
This work builds on the previous landmark reviews, 
and aims to capture recent, highest quality evidence 
(ie, randomised trials) in order to clarify the impact of 
providing patients access to EHRs. The main objective 
of this systematic review was to assess the impact of 
these interventions on the six dimensions of quality 
of care.
Methods
The Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses guidelines11 were followed in 
conducting this systematic review (online supplemen-
tary file 1). The study protocol was registered with 
the International Prospective Register of Systematic 
Reviews (PROSPERO) (CRD42017070092) and is 
available as an open access paper.12 Any differences 
between the protocol and review are described in 
online supplementary file 2.
search strategy
A systematic search of the literature published between 
1997 and 2017 was performed on Current Index to 
Nursing and Allied Health Literature (CINAHL), 
Cochrane, Embase, Health Management and Policy 
Database (HMIC), Medline/PubMed and PsycINFO, 
using free terms and controlled vocabulary, whenever 
supported.12 The reference lists of relevant articles 
(including systematic reviews), and grey literature 
(including PROSPERO, reports of relevant stakeholder 
organisations (NHS Digital, AMIA, eHealth at WHO, 
International Society for Telemedicine and eHealth), 
and conference proceedings (last 5 years) of related 
conferences (American Medical Informatics Associa-
tion, MedInfo, Medicine 2.0, Medicine X)) were also 
screened.
Study selection criteria
We included randomised trials only (see online supple-
mentary file 2) that met the following criteria: (1) 
Focused on adults subjects (eg, patients, carers). (2) 
Included an intervention consisting of sharing EHRs 
with patients (either isolated or as part of a multicom-
ponent intervention, that could include the identifi-
cation of discrepancies in records, messaging systems, 
access to educational material, or other). (3) Had an 
outcome evaluating at least one of the six domains 
of quality of care. Studies were excluded if they (1) 
Included participants aged 16 years and under. (2) Had 
an intervention consisting of health reminders only. (3) 
Only reported cognitive outcomes (eg, intent) or other 
subjective measures only (eg, subjective perception 
of health and/or well- being). The detailed screening 
strategy is described in the study protocol.12
Data extraction
One investigator extracted information from the 
included studies into a standardised computer- based 
spreadsheet, which was reviewed by a second investi-
gator for consistency. The data collected for each study 
included: name of the first author, year of publication, 
number of participants, participants’ characteristics 
and setting, date of the intervention, study duration, 
study design, intervention characteristics, domain of 
healthcare quality assessed, main outcomes (specifying 
if primary or secondary), effect size (means (SD) or 
% for every group, whenever possible; or difference 
between groups, if the only information available), 
statistical significance, overall quality score.
Risk of bias assessment
Risk of bias was evaluated using the Cochrane Risk 
of Bias Tool.13 Two investigators reviewed all eligible 
studies in order to appraise their risk of bias (ALN, LF; 
ALN, LL). A third investigator resolved disagreements 
(LL, LF). A study was considered as ‘overall low risk’ 
if scoring low risk for at least 50% of the criteria eval-
uated; otherwise, the study was considered having an 
‘overall high/unclear risk’.
Data synthesis and meta-analysis
A narrative synthesis of results was performed by 
domain of quality of care (IOM framework).2 For the 
meta- analysis, continuous outcomes representing the 
same variable and reported in at least four studies were 
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Figure 1 Flow diagram of included studies. CRT, cluster randomised trial; RCT, randomised controlled trial.
pooled using random effects. This was the case for 
HbA1c (reported as the percentage of glycated haemo-
globin over the total, %), and for systolic and dias-
tolic blood pressure (SBP and DBP, respectively; both 
reported in mm Hg). All effect sizes are shown as abso-
lute difference in means (DM) (weighted mean differ-
ence (WMD)) and classified as negative when in favour 
of the intervention, and positive when in favour of the 
control. Heterogeneity was assessed using I2 (<30%: 
low; 30%–60%: moderate; 60%–90%: substantial; 
>90%: considerable).13. The presence of publication 
bias was evaluated by a funnel plot. Comprehensive 
meta- analysis V.2.3. was used for statistical analysis.
Sensitivity analysis and subgroup analysis
For each domain of quality, we described the propor-
tion of studies showing beneficial effects in both ‘low 
risk’ and ‘unclear/high risk of bias’ groups. Sensitivity 
analyses were conducted, excluding high/unclear risk 
of bias studies (for HbA1c and SBP), and short- term 
interventions (lasting less than 12 months) for HbA1c. 
Further information is provided in online supplemen-
tary file 2.
Patient and public involvement
Our research question emerged from the implemen-
tation evaluation of the Care Information Exchange 
(https://www. care info rmat ione xchange- nwl. nhs. 
uk/), a portal/EHR with patient access available to 
2.4 million people in North- West London. Lay part-
ners will be involved in summarising the research find-
ings into lay summaries and reports.
results
The database search retrieved 6594 citations (figure 1). 
Titles and abstracts were screened, and 1698 duplicates 
were excluded, as well as 4801 articles that did not 
meet the inclusion criteria. After the full- text screening 
of the remaining articles (n=95), 72 additional papers 
did not meet inclusion criteria and were therefore 
excluded. The kappa statistic measuring intercoder 
agreement in title and abstract screening was 0.40 (fair 
agreement). Screening of reference lists of systematic 
reviews revealed 13 additional studies that met our 
predefined criteria. A total of 36 papers was obtained, 
which included 20 randomised trials (17 randomised 
controlled trials (RCTs) and 3 cluster randomised trial 
(CRTs)).
description of included studies
The 20 included studies involved a total of 17 387 
participants (table 1). Publication year ranged from 
1999 to 2013 and study duration varied between 3 
months and 32 months. Participants included had a 
range of health conditions, including type 2 diabetes 
(n=7),14–20 heart failure (n=2),21 22 arterial hyper-
tension (n=2),23 24 cancer (n=1),25 type 1 diabetes 
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Figure 2 Risk of bias assessment cells were colour- coded in orange for 
high risk of bias, in green for low risk of bias and in grey if risk of bias was 
unclear.
(n=1),26 fertility issues (n=1)27 and pregnancy.28 
Five studies included service users in general, without 
focusing on a specific health condition.29–33
summary of risk of bias assessment
Overall, 50% of the studies included (n=10) were 
considered good quality, scoring low risk in at least 
half of the domains evaluated in the risk of bias assess-
ment (figure 2).15 18 20 22 23 26–28 30 32. Four studies stood 
out with an overall low risk of bias for most of the 
domains evaluated.15 20 23 27 Due to the nature of the 
intervention, most studies scored a high risk of bias 
regarding blinding of participants and personnel; one 
study showed unclear risk.33 Blinding of the outcome 
assessment also showed a high risk of bias in several 
studies.14 17 21 22 24–26 28 29 31 32 Only three studies15 20 23 
provided information on trial protocol registration.
Interventions and retention rates
Although all interventions provided participants with 
web- based access to EHRs, the content made available 
varied greatly (table 1). Content available to partici-
pants included access to previous medical history and 
risk factors,15 20 24 25 28 29 31 test results,14 16–19 21 26 31–33 
medication lists,23 24 30 31 33 list of allergies,23 24 current 
health conditions,23 31 and clinical encounters and 
physician notes.26 31 One study specifically mentioned 
the existence of a functionality to download EHR 
data.31 In all studies, the patient access to EHRs was 
part of a complex intervention with other compo-
nents. Intervention components included educa-
tional materials,14 18–20 22 24–26 28 30–32 generation of 
personalised action plans/messages,15 26 31 32 self- 
management training,17 and medication and appoint-
ment reminders.15 16 Twelve studies included secure 
messaging systems.14 17 20–24 27 29–31 33 Two studies 
provided incentives (either financial,29 or use of the 
portal after the study),22 and one explicitly mentioned 
that no incentives were provided.18 Retention rates 
were calculated as the proportion of randomised 
patients in each study that completed follow- up. 
Three studies did not provide enough information 
to adequately calculate retention rates (total and per 
arm).14 19 32 Among the other studies, only one28 had a 
retention rate below 60%.
comparisons
In most studies, the comparator was usual care (ie, 
no patient access to EHRs).14–22 24 26 27 29 31 32 In three 
studies, the comparisons were active controls.28 30 33 Two 
studies comprised three arms,23 25 which are described 
in further detail in table 1.
outcomes
Most papers assessed outcomes covering more than 
one domain (median=2). The domain most frequently 
assessed was effectiveness (n=14), and the least 
frequently evaluated were timeliness and equity (n=0). 
Patient- centredness, safety and efficiency were evalu-
ated, respectively, in 11, 4 and 5 studies. A detailed 
overview of the outcomes evaluated is provided in 
online supplementary file 3.
Patient-centredness
Eleven studies evaluated the impact of sharing EHRs 
with patients on patient- centredness, including 
CRTs24 30 31 and eight RCTs.19–22 25–28 While six studies 
found a beneficial impact in at least one patient- 
centredness outcome,20 24–26 30 31 it is important to 
note that the exact measure of patient- centredness 
varied considerably across studies. Although patient 
satisfaction improved in two studies20 25 (46% vs 40%, 
p=0.04% and 27.7% vs 24.5%, p<0.0001, respec-
tively), two other failed to show a significant effect.22 27 
One study31 showed an increase in patient activation, 
as measured by the Patient Activation Measure34 (47 vs 
45, p=0.0014), but these results were not replicated 
in a similar study.24 Self- efficacy scores improved in 
one study26 using the Diabetes Empowerment Scale35 
(+0.14 vs −0.16, p=0.04), but no differences were 
found in two other studies22 27 using the Kansas City 
Cardiomyopathy Questionnaire (KCCQ) and the 
General Self- Efficacy Scale.36 Patient empowerment 
was accessed by the Patient Empowerment Scale37 in 
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Figure 3 Forest plots of effect sizes and 95% CIs representing the effect 
of interventions providing patients access to EHRs in HbA1c, SBP and DBP, 
using a random- effects model. The area of each square is proportional to 
the study's size, and therefore to its weight in the meta- analysis. For each 
study, CIs are represented by horizontal lines; a vertical line representing 
no effect is also plotted. The meta- analysed measure of effect is plotted as 
a diamond, the lateral points of which indicate CIs for this estimate. DBP, 
diastolic blood pressure; EHRs, electronic health records; HbA1c, glycated 
haemoglobin, SBP, systolic blood pressure.
two studies21 24 but a significant improvement in mean 
scores was found only in one (41.2 vs 40.1, p=0.019).24 
Three studies evaluated health literacy (ie, patients 
acknowledging to have learnt something new),19 25 28 
but only one found the intervention to be beneficial 
(96% vs 74%, p=0.02). Six out of 11 studies (54.5%) 
scored an overall low risk of bias. The proportion of 
studies showing a significant positive effect for at least 
one of the outcomes evaluated was 50% in low risk of 
bias studies, and 80% in the remaining studies.
Effectiveness
A total of 14 studies appraised the impact of providing 
patients with access to EHRs on effectiveness, including 
2 CRTs24 31 and 12 RCTs.14 15 17–20 22 23 25 26 32 33 Ten out 
of 14 studies (71.4%) demonstrated a positive impact 
on effectiveness- related outcomes.15 17–20 22 23 25 31 32 
These studies evaluated the impact on a wide range of 
health conditions, including depression and anxiety,25 
heart failure,22 cardiovascular risk (Framingham 
Score),20 obesity,15 23 smoking status,15 adherence 
to preventive services31 32 dyslipidaemia,17 18 20 24 33 
diabetes14 15 17–20 26 33 and hypertension.15 17 18 20 23 24 33 
In one study using the Hospital Anxiety and Depres-
sion Scale,38 patient access to EHRs did not change 
patients’ depression scores, and patients in the general 
computer information group were more anxious than 
the ones accessing personal records (DM=+18%, 
95% CI 3.7 to 26.5, p=0.001).25 One study found a 
dramatic improvement in symptom stability scores, 
assessed by the KCCQ (DM:+17, 95% CI 9 to 29, 
p<0.001).22 Two studies found an improvement in 
LDL- cholesterol levels.17 20 No significant changes 
were observed on triglycerides,17 high- density lipo-
protein (HDL)- cholesterol,17 total cholesterol,18 body 
weight,15 23 smoking status15 or total cardiovascular 
risk.20 Adherence to preventive services improved 
in the two studies evaluating this aspect31 32 (ie, use 
of low- dose aspirin (84.4% vs 67.6%, p<0.0001), 
complete immunisation (95.5% vs 87.2%, p=0.044), 
and uptake of cancer screening (increases ranging from 
10.3% to +14.3%, all p<0.05)).While two studies 
specifically evaluated adherence to pneumococcal 
immunisation,31 32 only one found a beneficial effect.31
Seven out of 14 studies scored an overall low risk 
of bias (50.0%). The proportion of studies showing a 
positive effect was 85.7% in the low risk of bias group, 
and 57.1% in the remaining studies.
Meta-analysis
Data from RCTs evaluating HbA1c and SBP were 
pooled together, and the respective meta- analyses 
performed. The six studies evaluating HbA1c17–20 26 33 
comprised 950 participants, from which 894 completed 
follow- ups. Meta- analyses showed a beneficial effect 
in effectiveness by reducing HbA1c (unit, %; WMD= 
−0.316; 95% CI −0.540 to −0.093, p=0.005, I2=0%) 
(figure 3), which remained significant in sensitivity 
analyses for low risk of bias studies (WMD= −0.405; 
95% CI −0.711 to −0.099) (online supplementary 
figure 1), and long- term interventions only (WMD= 
−0.272; 95% CI −0.482 to −0.062) (online supple-
mentary figure 2). It is important to note that the study 
showing a high risk of bias,19 was also the one showing 
the smallest study sample. The funnel plot indicates 
asymmetry (online supplementary figure 3), suggesting 
potential publication bias.
The four studies evaluating the impact on blood 
pressure17 18 20 23 (comprising 1308 participants, of 
which 1021 completed follow- ups) were pooled in 
a meta- analysis, and showed a significant beneficial 
effect in SBP (unit: mm Hg; WMD=−1.416; 95% 
CI −2.814 to −0.018, p=0.047, I2=0%) (figure 3). 
However, significance was lost after removing the 
high/unclear risk of bias study17 (WMD=−1.375; 
95% CI −2.791 to 0.041) (online supplementary 
figure 1). No significant effect was found in DBP in the 
meta- analysis (unit: mm Hg; WMD=−0.918; 95% CI 
−2.078 to 0.242, p=0.121, I2=0%) (figure 3), nor in 
the sensitivity analysis for low risk of bias studies only 
(WMD=−0.916; 95% CI −2.089 to 0.257) (online 
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supplementary figure 1). The funnel plots appear 
symmetrical for SBP and DBP (online supplementary 
figures 4 and 5), indicating a similar proportion of 
studies in each direction of the effect size.
Safety
All studies19 22 29 30 showed a beneficial effect for at least 
one of the outcomes evaluated (online supplementary 
file 3). Two studies evaluated adherence, including 
general adherence to medical regimens22 (using the 
General Adherence Scale from the Medical Outcomes 
Study (MOS)39 and medication adherence.22 29 
General adherence (MOS Scores) improved with the 
intervention22 (+2.3, 95% CI −3.7 to 8.3, p=0.01), 
but no significant changes were found in adherence to 
medication.22 29 A beneficial effect was observed in all 
studies evaluating medication safety,19 29 30 including a 
higher likelihood of reporting discrepancies (53% vs 
24%, p<0.01),29 to change medications19 29 (88.3% vs 
67.2%, p<0.01; and 84% vs 23%, p=0.002, respec-
tively), and a resulting slightly lower proportion of 
patients with medication discrepancies (29% vs 30%, 
p=0.01).30 Two out of four studies scored an overall 
low risk of bias, and the proportion of studies showing 
a positive effect was the same in both risk groups 
(100.0%).
Efficiency
The impact of providing patients with access to EHRs 
was assessed in five studies.16 18 22 24 31 As less than four 
studies assessed the same construct, meta- analysis was 
not performed, and a descriptive analysis is provided. 
Number of hospitalisations per subject was lower in 
one study (0.17 vs 0.20, p=0.01),16 while total number 
remained unchanged in another (22 vs 21, p=1.00).22 
Length of stay (in days) did not change in two studies 
(+0.2 vs –0.3, and 0.42 vs 0.34, respectively),18 24 but 
was shorter in another (0.99 vs 1.1, p<0.01).16 In 
the three studies evaluating the number of emergency 
visits, total numbers were either reduced,16 increased22 
or remained unchanged.24 Number of primary care 
visits was lower in one study (2.9 vs 4.3, p<0.0001),31 
but no changes were observed in another (0.0 vs 
–0.2).18 Two out of five studies scored an overall low 
risk of bias, and the proportion of studies showing a 
positive effect was 50.0% and 66.7% in low- risk and 
high/unclear- risk groups, respectively.
Timeliness and equity
While none of the studies assessed either timeliness or 
equity as primary outcome, three studies21 24 32 eval-
uated the predictors of usage of EHRs by patients. 
Earnest et al21 did not find any associations between 
usage and race, symptom scores or number of visits; 
two studies found significant associations between 
usage and higher education,32 number of illnesses,32 
younger age,24 clinic attended by the patient24 
self- reported computer skills,24 and higher number of 
internet- use items.24
dIscussIon
Key findings in context of published literature
This work systematically appraised the impact of EHRs 
with patient access across the six domains of quality 
of care as defined by the IOM:2 patient- centredness, 
effectiveness, efficiency, safety, timeliness and equity.
Regarding patient- centredness, results were incon-
sistent. More than half of the studies included in this 
domain showed a significant positive effect for at least 
one outcome, but no clear effect was found for specific 
outcomes, such as patient satisfaction, patient activa-
tion, self- efficacy, patient empowerment or health 
literacy. These results are line with previous studies5 6 8 
that found mixed evidence about the impact in patient- 
centred outcomes. While providing patients access to 
EHRs is envisaged as a key strategy to deliver patient- 
centred care, the diversity of outcomes evaluated, and 
scales and tools used, hinders pooling of results and 
the use of meta- analytical approaches. It is critical, 
therefore, to identify and standardise measures and 
constructs to evaluate patient- centredness, to allow the 
application of meta- analytical methods in this domain.
A few studies included showed a positive impact 
in effectiveness in a range of outcomes (ie, anxiety, 
cardiac symptoms, LDL- cholesterol), but no signif-
icant improvements were found for triglycerides, 
HDL- cholesterol, total cholesterol, body weight, 
smoking status or total cardiovascular risk. Two addi-
tional studies not captured by our search also suggest 
that providing patients access to EHRs may improve 
glaucoma control40 and quality of life in patients with 
asthma.41 A positive effect was also found in adher-
ence to several preventive services (ie, use of low- 
dose aspirin, cancer screening), an approach that 
can be particularly relevant in the context of cancer 
screening, where higher expected adherence rates 
have the potential to reduce cancer incidence and 
mortality.42 However, the number of studies published 
per outcome is limited, and further research is needed 
to increase meta- analytical power and explore the size 
and impact of the potential effect in specific health 
conditions.
Our meta- analysis showed a beneficial effect on 
HbA1c reduction, which remained significant after 
removing low/unclear- risk studies, or studies in which 
the intervention lasted less than 12 months. In 2013, 
Goldzweig et al identified several examples of improved 
outcomes for patients with chronic diseases (including 
hypertension and diabetes).8 In 2012, Ammenw-
erth et al7 performed a systematic review of studies 
published between 1990 and 2011 and concluded that 
there was insufficient evidence to document a bene-
ficial effect in effectiveness in patients with access 
to EHRs. However, by then only two studies (out 
of the four included in the review) investigated the 
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effect on health outcomes. Our meta- analysis demon-
strates a mean reduction in absolute values of HbA1c 
of 0.316% (95% CI −0.540% to −0.093%), with a 
low heterogeneity (I2=0.0) reflecting the specificity 
of our inclusion criteria. These results have important 
clinical implications, since an absolute reduction of 
1 point on HbA1c levels (expressed in the same unit 
considered in our meta- analysis) is associated with 
a significant reduction of deaths related to diabetes 
(−21%), myocardial infarction (−14%) and microvas-
cular complications (−37%).43 Visual inspection of the 
funnel plot suggests a potential publication bias, with 
studies with a lower precision (higher SE) reporting a 
greater beneficial effect. However, the meta- analysed 
effect remained significant after removing the study 
that stood out with a smallest sample size.19
Although our meta- analysis found a beneficial effect 
in SBP, statistical significance was lost in sensitivity 
analysis for low risk of bias studies only; no significant 
effect was found in DBP. It must be noted, however, 
that the number of studies included is low, and further 
evidence is needed to establish robust conclusions.
For the efficiency domain, most studies included 
found either no change, or a reduction of healthcare 
usage (in primary care visits,31 or inpatient or emer-
gency contacts).16 Ammenwerth et al,7 have also previ-
ously suggested a significant reduction in office visit 
rates. Further studies are required to clarify the impact 
on this dimension and pave the way to meta- analytical 
approaches that can provide further insights on the 
effect size in the various dimensions of healthcare 
usage.
Our work suggests that the intervention improves 
general adherence, but not medication adherence—
however, a strong body of evidence showed a posi-
tive effect in medication safety. A previous study has 
suggested that patients find this approach valuable, 
and reported either unchanged or improved rela-
tionships with their clinician when using it.44 Further 
studies should further explore patients’ willingness 
and ability to report errors in their records, and also 
which specific groups are most likely to benefit. These 
results are in line with the findings of Mould et al, 
de Lusignan et al and Ammenwerth et al, who previ-
ously suggested that these digital solutions positively 
impacted patient safety.6 7 9
Finally, we found no studies specifically focusing on 
the impact on timeliness or equity. Uptake of portals 
may differ by patient- specific factors, with lower use by 
racial and ethnic minorities, patients with lower educa-
tion level or literacy, thus leading to digital- led health 
inequities.8 Davis Giardina et al5 reported that, up to 
2012, no studies had assessed any of these domains. 
Eight years later, these aspects remain unexplored.
strengths and limitations
Five landmark reviews have been published to date 
evaluating the impact of EHRs with patient access 
on different aspects of quality of care.5–9 Only one 
systematic review had focused on randomised trials, 
having found two studies investigating the impact on 
effectiveness.7
Our systematic review included studies published 
between 1997 and 2017 and retrieved a total of 20 
randomised trials. This study has several strengths: a 
predefined, openly available protocol was followed12 
(with any changes described in online supplemen-
tary file 2); only randomised trials were included; 
focused exclusively on EHRs; and impact was assessed 
in all domains of quality of care, with meta- analysis 
performed whenever possible.
Only half of the studies included had an overall low 
risk of bias score. A possible approach to improve 
blinding in web- based interventions, or to test the 
impact of specific components, could be using A/B 
testing, a technique used for website optimisation that 
compares variation against a standard experience, and 
determines which variant is more effective.45
conclusIon
Our results suggest that providing patients with access 
to EHRs can improve patient safety and effectiveness. 
More methodologically robust studies are necessary 
to increase the strength of these conclusions, and to 
enhance meta- analytical power. For EHRs with patient 
access to be broadly used, it is important to focus on 
interventions that enhance adoption and measure 
usage, and issues of equity in both aspects need to be 
addressed by policy makers when implementing such 
programmes.46
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